Clinical Update: Cutaneous Drug Eruptions

Cutaneous drug eruptions are the most common adverse reactions to medications. When cutaneous drug eruptions occur, they most commonly appear as a maculopapular rash. More serious adverse reactions include Stevens-Johnson syndrome and toxic epidermal necrolysis. Stevens-Johnson syndrome usually begins with flu-like symptoms and then progresses to skin pain, facial and tongue swelling, and blistering and sloughing of the skin, including the eyes, lips, mouth and genital region. In toxic epidermal necrolysis (TEN), the top layer of the skin detaches. Both Steven-Johnson syndrome and toxic epidermal necrolysis require immediate medical attention.

Some cutaneous adverse reactions occur within days while others may present after long-term use of the offending drug. Drugs commonly associated with cutaneous drug eruptions include:
  • penicillins
  • cephalosporins
  • sulfonamides
  • carbamazepine
  • hydantoins
  • allopurinol
  • gold.

This Just In

From Our Journals

*Access to CE articles is through Lippincott's NursingCenter.com. To return to the Skincare Network from NursingCenter, click the Skincare Network link under the Specialty Sites navigation button.

 Management of Treatment-Induced Dermatologic Toxicities in Palliative Care
Journal of Hospice and Palliative Nursing
January/February 2012

The Case of the Cutaneous Quandary
Advanced Emergency Nursing Journal
December 2011

 
Journal of the Dermatology Nurses' Association
November/December 2009


 CHALLENGES IN PRACTICE: Topical Treatment Protocol for Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
Journal of Wound, Ostomy and Continence Nursing
May/June 2009

 

On The Web



 
 

jQuery UI Accordion - Default functionality

For life-long learning and continuing professional development, come to Lippincott's NursingCenter.

 
DNA.jpg      ASPSN.jpg
Nursing Jobs Plus
Featured Jobs
Recommended CE Articles Recommended Nursing Articles

What internal motivators drive RNs to pursue a BSN?
Nursing2014 , October 2014
Free access will expire on November 24, 2014.


Breast Cancer Risk Assessment in Primary Care
MCN, The American Journal of Maternal/Child Nursing, September/October 2014
Free access will expire on November 10, 2014.


Nurses spurring innovation
Nursing Management, October 2014
Free access will expire on November 10, 2014.


More Recommended Articles

Subscribe to Recommended Articles

Evidence Based Practice Skin Care Network NursingCenter Quick Links What’s Trending Events